Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	21099
Country	Netherlands

Received	2015-06-30 14:46
Peer-Review Started	2015-07-01 11:10
To Make the First Decision	2015-09-28 11:51
Return for Revision	2015-09-30 13:45
Revised	2015-10-10 00:00
Second Decision	2015-11-02 14:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-11-11 18:03
Articles in Press	2015-11-11 18:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-23 20:21
Publish the Manuscript Online	2016-01-31 19:20

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Editorial
Article Title	Clinical applicability of immunotherapy of cervical intraepithelial neoplasia
Manuscript Source	Invited Manuscript
All Author List	Margot Koeneman, Roy Kruitwagen and Arnold-Jan Kruse
Funding Agency and Grant Number
Corresponding Author	Arnold-Jan Kruse, MD, PhD, Department of Obstetrics and Gynecology, Maastricht University Medical Center, Postbus 5800, 6202 AZ Maastricht, the Netherlands. arnoldjankruse@hotmail.com
Key Words	Cervix; Cervical intraepithelial neoplasia; Large loop excision of the transformation zone; Immuno­therapy; Regression; Human papillomavirus
Core Tip	Immunotherapy for cervical intraepithelial neoplasia (CIN) is discussed in light of the natural history of CIN. The pros and cons of the current standard therapy (large loop excision of the trans-formation zone) and immunotherapy, potential side effects, and available evidence supporting the use of immunotherapy in CIN are addressed.
Publish Date	2016-01-31 19:20
Citation	Koeneman M, Kruitwagen R, Kruse AJ. Clinical applicability of immunotherapy of cervical intraepithelial neoplasia. World J Obstet Gynecol 2016; 5(1): 1-4
URL	http://www.wjgnet.com/2218-6220/full/v5/i1/1.htm
DOI	http://dx.doi.org/10.5317/wjog.v5.i1.1

Full Article (PDF)	WJOG-5-1.pdf
Full Article (Word)	WJOG-5-1.doc
Manuscript File	21099-Review.docx
Answering Reviewers	21099-Answering reviewers.pdf
Audio Core Tip	21099-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	21099-Conflict-of-interest statement.pdf
Copyright License Agreement	21099-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	21099-Language certificate.pdf
Peer-review Report	21099-Peer-review(s).pdf
Scientific Misconduct Check	21099-Scientific misconduct check.pdf
Scientific Editor Work List	21099-Scientific editor work list.pdf